Internal Medicine
Partner With Us
Advertisement
Conexiant chevron_right Internal Medicine chevron_right Shorter Prostate Radiotherapy Proves LongTerm Match
From the Journals Conference News European Society for Radiotherapy and Oncology (ESTRO) 2025

Shorter Prostate Radiotherapy Proves Long-Term Match

Two-week radiation treatment for localized prostate cancer delivers equivalent 10-year outcomes to standard 8-week course in a clinical trial.

Conexiant
article Full Article subject Summary summarize Notecard
  1. Ultra-hypofractionated radiotherapy over 2.5 weeks is as effective as standard 8-week course for localized prostate cancer.
  2. Long-term outcomes confirm durable cancer control and similar adverse effects.
  3. The trial, HYPO-RT-PC, enrolled 1,200 men with intermediate- to high-risk localized prostate cancer.
  4. Failure-free survival after 10 years: 72% (short-course) vs 65% (standard-course).
  5. Overall survival after 10 years: 81% (short-course) vs 79% (standard-course).
  6. Urinary and bowel symptoms were similar in both groups, with most being mild to moderate.

Source: ESTRO 2025

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.